Reassessing Renal Artery Stenting and Sacubitril/ Valsartan Use in Hemodialysis patients: A Critical Review
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 9 | Views: 248 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

New Innovation and Idea | Medical Science | Croatia | Volume 12 Issue 11, November 2023 | Popularity: 5.1 / 10


     

Reassessing Renal Artery Stenting and Sacubitril/ Valsartan Use in Hemodialysis patients: A Critical Review

Ljiljana Fodor Duric


Abstract: This article critically evaluates the use of renal artery stenting and sacubitrilvalsartan in hemodialysis patients. It explores the risks and benefits, considering recent studies and clinical trials. The focus is on the potential impact on patient outcomes, particularly in managing renovascular hypertension and cardiovascular complications associated with chronic kidney disease.


Keywords: Renal Artery Stenting, SacubitrilValsartan, Hemodialysis, Renovascular Hypertension, Chronic Kidney Disease


Edition: Volume 12 Issue 11, November 2023


Pages: 2123 - 2124


DOI: https://www.doi.org/10.21275/SR231128155130


Please Disable the Pop-Up Blocker of Web Browser

Verification Code will appear in 2 Seconds ... Wait



Text copied to Clipboard!
Ljiljana Fodor Duric, "Reassessing Renal Artery Stenting and Sacubitril/ Valsartan Use in Hemodialysis patients: A Critical Review", International Journal of Science and Research (IJSR), Volume 12 Issue 11, November 2023, pp. 2123-2124, https://www.ijsr.net/getabstract.php?paperid=SR231128155130, DOI: https://www.doi.org/10.21275/SR231128155130

Top